GRIS-PEG 250 (Griseofulvin (Ultramicrocrystalline) 250 mg)
Pill with imprint GRIS-PEG 250 is White, Capsule-shape and has been identified as Griseofulvin (Ultramicrocrystalline) 250 mg. It is supplied by Oceanside Pharmaceuticals, Inc..
Griseofulvin is used in the treatment of dermatophytosis; onychomycosis, toenail; onychomycosis, fingernail; tinea barbae; tinea capitis and belongs to the drug class miscellaneous antifungals. Risk cannot be ruled out during pregnancy. Griseofulvin 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for GRIS-PEG 250
Griseofulvin (Ultramicrocrystalline)
- Imprint
- GRIS-PEG 250
- Strength
- 250 mg
- Color
- White
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Miscellaneous antifungals
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Oceanside Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 68682-0520
Related Images for "GRIS-PEG 250"
More about griseofulvin
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 15 Reviews
- Drug class: miscellaneous antifungals
- FDA Alerts (1)
Consumer resources
- Patient Information
- Griseofulvin (Advanced Reading)
- Griseofulvin Microsize Tablets
- Griseofulvin Ultramicrosize Tablets
- Griseofulvin Microsize Oral Suspension
- Other brands
- Grifulvin V, Fulvicin P/G, Gris-PEG, Fulvicin U/F
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.